scispace - formally typeset
A

Abel Sánchez-Aguilera

Researcher at Carlos III Health Institute

Publications -  16
Citations -  4763

Abel Sánchez-Aguilera is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Lymphoma & Reed–Sternberg cell. The author has an hindex of 13, co-authored 16 publications receiving 4500 citations. Previous affiliations of Abel Sánchez-Aguilera include University of Valencia.

Papers
More filters
Journal ArticleDOI

Epigenetic differences arise during the lifetime of monozygotic twins

TL;DR: Older monozygous twins exhibited remarkable differences in their overall content and genomic distribution of 5-methylcytosine DNA and histone acetylation, affecting their gene-expression portrait, indicating how an appreciation of epigenetics is missing from the understanding of how different phenotypes can be originated from the same genotype.
Journal ArticleDOI

Cell cycle deregulation in B-cell lymphomas.

TL;DR: The current knowledge of the alterations in each of these pathways is discussed, with special emphasis on the deregulation of cell cycle progression, in an attempt to integrate the available information within a global model that describes the contribution of these molecular changes to the genesis and progression of B-cell lymphomas.
Journal ArticleDOI

A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis

TL;DR: The results suggest that EMT-related genes contribute to the promotion of the metastatic phenotype in primary CMM by supporting specific adhesive, invasive, and migratory properties.
Journal ArticleDOI

Splenic marginal zone lymphoma. Proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis

TL;DR: Characterizing this tumor more comprehensively, and of identifying new diagnostic and prognostic markers, cDNA microarray expression profiling and tissue microarray immunohistochemical studies in a relatively large series of 44 SMZLs revealed a largely homogenous signature, implying the existence of a single molecular entity.